Hakutulokset - Heinz Wiendl

Tarkenna hakua
  1. 1
    CD8<sup>+</sup>T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability

    CD8<sup>+</sup>T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability Tekijä Nico Melzer, Sven G. Meuth, Heinz Wiendl

    Julkaistu 2009
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system

    Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system Tekijä Nico Melzer, Sven G. Meuth, Heinz Wiendl

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis

    Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis Tekijä Nicholas Schwab, Tilman Schneider‐Hohendorf, Heinz Wiendl

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    TRPM2 Cation Channels Modulate T Cell Effector Functions and Contribute to Autoimmune CNS Inflammation

    TRPM2 Cation Channels Modulate T Cell Effector Functions and Contribute to Autoimmune CNS Inflammation Tekijä Nico Melzer, Gordon Hicking, Kerstin Göbel, Heinz Wiendl

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond

    Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond Tekijä Tobias Ruck, Stefan Bittner, Heinz Wiendl, Sven G. Meuth

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Neurons as targets for T cells in the nervous system

    Neurons as targets for T cells in the nervous system Tekijä Roland Liblau, Daniel Gonzalez‐Dunia, Heinz Wiendl, Frauke Zipp

    Julkaistu 2013
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    From the Background to the Spotlight: TASK Channels in Pathological Conditions

    From the Background to the Spotlight: TASK Channels in Pathological Conditions Tekijä Stefan Bittner, Thomas Budde, Heinz Wiendl, Sven G. Meuth

    Julkaistu 2010
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Gut–CNS-Axis as Possibility to Modulate Inflammatory Disease Activity—Implications for Multiple Sclerosis

    Gut–CNS-Axis as Possibility to Modulate Inflammatory Disease Activity—Implications for Multiple Sclerosis Tekijä Ann-Katrin Fleck, Detlef Schuppan, Heinz Wiendl, Luisa Klotz

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature

    Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature Tekijä Catharina Korsukewitz, Stephen W. Reddel, Amit Bar‐Or, Heinz Wiendl

    Julkaistu 2020
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Bruton tyrosine kinase inhibitors for multiple sclerosis

    Bruton tyrosine kinase inhibitors for multiple sclerosis Tekijä Julia Krämer, Amit Bar‐Or, Timothy J. Turner, Heinz Wiendl

    Julkaistu 2023
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    IL-17 Silencing Does Not Protect Nonobese Diabetic Mice from Autoimmune Diabetes

    IL-17 Silencing Does Not Protect Nonobese Diabetic Mice from Autoimmune Diabetes Tekijä Julie Joseph, Stefan Bittner, Fabian Kaiser, Heinz Wiendl, Stephan Kissler

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Myelin Oligodendrocyte Glycoprotein (MOG&lt;sub&gt;35-55&lt;/sub&gt;) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice

    Myelin Oligodendrocyte Glycoprotein (MOG&lt;sub&gt;35-55&lt;/sub&gt;) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice Tekijä Stefan Bittner, Ali Maisam Afzali, Heinz Wiendl, Sven G. Meuth

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Can cognitive assessment really discriminate early stages of Alzheimer’s and behavioural variant frontotemporal dementia at initial clinical presentation?

    Can cognitive assessment really discriminate early stages of Alzheimer’s and behavioural variant frontotemporal dementia at initial clinical presentation? Tekijä Sophia Reul, Hubertus Lohmann, Heinz Wiendl, Thomas Duning, Andreas Johnen

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Generating microglia from human pluripotent stem cells: novel in vitro models for the study of neurodegeneration

    Generating microglia from human pluripotent stem cells: novel in vitro models for the study of neurodegeneration Tekijä Anna M. Speicher, Heinz Wiendl, Sven G. Meuth, Matthias Pawlowski

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Targeting B cells in relapsing–remitting multiple sclerosis: from pathophysiology to optimal clinical management

    Targeting B cells in relapsing–remitting multiple sclerosis: from pathophysiology to optimal clinical management Tekijä Stefan Bittner, Tobias Ruck, Heinz Wiendl, Oliver Grauer, Sven G. Meuth

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Teriflunomide and Its Mechanism of Action in Multiple Sclerosis

    Teriflunomide and Its Mechanism of Action in Multiple Sclerosis Tekijä Amit Bar‐Or, Andrew R. Pachner, Françoise Menguy-Vacheron, Johanne Kaplan, Heinz Wiendl

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients

    Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients Tekijä Ute Feger, Claudia Luther, Simone Poeschel, Arthur Melms, Eva Tolosa, Heinz Wiendl

    Julkaistu 2007
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    The role of dendritic cells in CNS autoimmunity

    The role of dendritic cells in CNS autoimmunity Tekijä Alla L. Zozulya, Benjamin D. Clarkson, Sonja Ortler, Zsuzsanna Fábry, Heinz Wiendl

    Julkaistu 2010
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Benefit–Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis

    Benefit–Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis Tekijä Gıancarlo Comı, Hans‐Peter Hartung, Rajesh Bakshi, Ian M. Williams, Heinz Wiendl

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Neonatal Fc Receptor–Targeted Therapies in Neurology

    Neonatal Fc Receptor–Targeted Therapies in Neurology Tekijä Christopher Nelke, Marianna Spatola, Christina B. Schroeter, Heinz Wiendl, Jan D. Lünemann

    Julkaistu 2022
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: